Faculty profile

Laura Dawson

Back to faculty

ProfessorDepartment of Radiation OncologyUniversity of Toronto

Laura Dawson

Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
14 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

132

Citations

h-index

139

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Clinical oncology

Latest papers

Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): study protocol for a phase III randomized controlled trial.
Contemporary clinical trials · 2026
Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.
Advances in radiation oncology · 2026
Letter to the Editor.
Clinical and translational radiation oncology · 2024 · senior author

All 30 publications

Latest funding

Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)
CIHR · 2026 · Co-investigator
$960,076
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)
CIHR · 2025 · Principal investigator
$210,000
A Finite Element Model Approach to Modeling Changes of the Head and Neck
CIHR · 2011 · Co-investigator
$100,000

All 5 grants and awards

30 publications.

Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): study protocol for a phase III randomized controlled trial.

Wong H, Ng SSW, Mohamad I, Alborz J, Stanescu T, Liu ZA, De Leon J, Tan H, Ng SP, Radhakrishna G, Bahij R, Intven M, Kirichenko A, Mesci A, Yan M, Dawson L, Augilera T, Hosni A

Contemporary clinical trials2026

DOI: 10.1016/j.cct.2026.108381 PMID: 42309387

Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.

Chelvarajah RC, Bartolucci DD, Javor J, Taylor E, Liu ZA, Ye XY, Serban M, Cummings B, Dawson L, Keilty D, Hahn E, Tsai CJ, Wong P

Advances in radiation oncology2026

DOI: 10.1016/j.adro.2026.102088 PMID: 42382438

Letter to the Editor.

Chuong MD, Hosni A, Kharofa J, Reyngold M, Sanford N, Rubio Rodriguez M, Dawson L

Clinical and translational radiation oncology2024Senior author

DOI: 10.1016/j.ctro.2024.100841 PMID: 39262840

Disparities in outcomes and access to therapy options in hepatocellular carcinoma.

Beltrán Ponce S, Gokun Y, Douglass F, Dawson L, Miller E, Thomas CR, Pitter K, Conteh L, Diaz DA

Journal of the National Cancer Institute2024

DOI: 10.1093/jnci/djad213 PMID: 37831897

Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.

Olson R, Abraham H, Leclerc C, Benny A, Baker S, Matthews Q, Chng N, Bergman A, Mou B, Dunne EM, Schellenberg D, Jiang W, Chan E, Atrchian S, Lefresne S, Carolan H, Valev B, Tyldesley S, Bang A, Berrang T, Clark H, Hsu F, Louie AV, Warner A, Palma DA, Howell D, Barry A, Dawson L, Grendarova P, Walker D, Sinha R, Tsai J, Bahig H, Thibault I, Koul R, Senthi S, Phillips I, Grose D, Kelly P, Armstrong J, McDermott R, Johnstone C, Vasan S, Aherne N, Harrow S, Liu M

BMC cancer2024

DOI: 10.1186/s12885-024-11905-7 PMID: 38310262

Advances and Challenges in Trials of Local Therapy for Patients With Oligometastatic or Oligoprogressive Disease.

Yan M, Abdel-Rahman F, Dawson L, Wong P, Wong RKS, Tsai CJ

Seminars in radiation oncology2023

DOI: 10.1016/j.semradonc.2023.07.001 PMID: 37684071

Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma.

Herman M, Lok BH, Gallinger S, Dawson L, Kim R, Cheng D, Paton T, Bucur R, Patel D, Fazelzad R, Hueniken K, Liu G

Translational gastroenterology and hepatology2023

DOI: 10.21037/tgh-23-22 PMID: 38021355

Beyond Diversity Toward Inclusion, Belonging, and Safety.

Gibbs IC, Jacobson G, Dawson L, Michalski JM, Sandler H, Deville C

International journal of radiation oncology, biology, physics2023

DOI: 10.1016/j.ijrobp.2023.03.050 PMID: 37179085

2023 Canadian Surgery Forum

Brière R, Habashi R, Merchant S, Cadili L, Alhumoud Z, Lau R, Gawad N, Valji R, Balmes PN, Tan JGK

Canadian Journal of Surgery20231 citationsOpen Access

DOI: 10.1503/cjs.014223 PMID: W4389488805

Stereotactic body radiation therapy for colorectal liver metastases.

Mohamad I, Barry A, Dawson L, Hosni A

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group2022

DOI: 10.1080/02656736.2021.1923836 PMID: 35465818

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Laura Dawson

Research

Latest papers

Latest funding

Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): study protocol for a phase III randomized controlled trial.

Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.

Letter to the Editor.

Disparities in outcomes and access to therapy options in hepatocellular carcinoma.

Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.

Advances and Challenges in Trials of Local Therapy for&#xa0;Patients With Oligometastatic or Oligoprogressive Disease.

Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma.

Beyond Diversity Toward Inclusion, Belonging, and Safety.

2023 Canadian Surgery Forum

Stereotactic body radiation therapy for colorectal liver metastases.

Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC (The SOCRATES HCC Study)

A Finite Element Model Approach to Modeling Changes of the Head and Neck

Radiation Therapy and Sorafenib for Primary and Metastatic Liver Cancer

The Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research for the 21st Century (EIRR21) at CIHR

Frequent collaborators

John Kim

Teodor Stanescu

Jelena Lukovic

Gonzalo Sapisochin

Steven Gallinger

Philip Wong

Michael Milosevic

Michael Yan

David Jaffray

Lawrence Gillman

Michael Verret

Alaa Rostom

Jing Zhang

Gianni Lorello

Carol Swallow

Lisa Wang

Ian Ball

Kathryn Roth

Ahmad Elnahas

Juan Glinka

Jeffrey Hawel

Sarah Knowles

Jennifer Lam

Bradley Moffat

Neil Parry

Natashia Seemann

Anton Skaro

Shane Smith

Pamela Ohashi

Vickie Baracos

Michael Verret

Edward Passos

Gregg Nelson

Sunil Patel

Nazia Selzner

Robert Olson

Erin Kennedy

Tulin Cil

Kimberly LeBlanc

Antoine Eskander

Advances and Challenges in Trials of Local Therapy for Patients With Oligometastatic or Oligoprogressive Disease.